{"id":14564,"date":"2026-04-08T06:00:00","date_gmt":"2026-04-08T10:00:00","guid":{"rendered":"https:\/\/cov19longhaulfoundation.org\/?p=14564"},"modified":"2026-03-25T13:09:41","modified_gmt":"2026-03-25T17:09:41","slug":"nail-manifestations-of-sars-cov-2-infection-covid-19-etiology-pathophysiology-histopathology-clinical-features-and-outcomes","status":"publish","type":"post","link":"https:\/\/cov19longhaulfoundation.org\/?p=14564","title":{"rendered":"Nail Manifestations of SARS-CoV-2 Infection (COVID-19): Etiology, Pathophysiology, Histopathology, Clinical Features, and Outcomes"},"content":{"rendered":"\n<p class=\"has-small-font-size\">John Murphy, CEO, The COVID-19 Long Haul Foundation<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Abstract<\/h2>\n\n\n\n<p>SARS-CoV-2 infection has been associated with delayed nail abnormalities including Beau\u2019s lines, onychomadesis, transverse leukonychia, and chromonychia (\u201cCOVID nails\u201d). These manifestations reflect systemic inflammatory, vascular, and metabolic stress affecting the nail matrix rather than direct viral invasion. This review synthesizes current evidence regarding the etiologic mechanisms, molecular and vascular pathophysiology, histopathologic correlates, clinical spectrum, and outcomes of COVID-19\u2013associated nail disease.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">1. Introduction<\/h1>\n\n\n\n<p>COVID-19\u2013associated nail abnormalities are increasingly recognized as part of the post-acute dermatologic sequelae of SARS-CoV-2 infection. The nail unit functions as a slow-growing epithelial structure that records systemic physiological disturbances occurring weeks to months earlier.<\/p>\n\n\n\n<p>Unlike cutaneous rashes seen during acute infection, nail findings are typically <strong>post-infectious markers of systemic stress<\/strong>, reflecting transient dysfunction of the nail matrix due to fever, hypoxia, inflammation, and microvascular injury.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">2. Etiology<\/h1>\n\n\n\n<h2 class=\"wp-block-heading\">2.1 Indirect systemic mechanism<\/h2>\n\n\n\n<p>The prevailing model is that nail abnormalities arise from:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cytokine-mediated suppression of keratinocyte proliferation<\/li>\n\n\n\n<li>Fever-associated arrest of nail matrix growth<\/li>\n\n\n\n<li>Microvascular endothelial dysfunction<\/li>\n\n\n\n<li>Hypoxemia-induced metabolic stress<\/li>\n\n\n\n<li>Hospitalization-related physiologic stress<\/li>\n<\/ul>\n\n\n\n<p>Direct infection of nail matrix cells has not been demonstrated.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">2.2 Viral-host interaction pathways<\/h2>\n\n\n\n<p>SARS-CoV-2 induces systemic pathways relevant to nail pathology:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ACE2 downregulation \u2192 angiotensin II excess \u2192 vasoconstriction<\/li>\n\n\n\n<li>IL-6, TNF-\u03b1, IL-1\u03b2 elevation \u2192 keratinocyte growth arrest<\/li>\n\n\n\n<li>Endothelial activation \u2192 microthrombi formation<\/li>\n<\/ul>\n\n\n\n<p>These systemic changes indirectly impair nail matrix function.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">3. Pathophysiology<\/h1>\n\n\n\n<h2 class=\"wp-block-heading\">3.1 Nail matrix arrest syndrome<\/h2>\n\n\n\n<p>The nail matrix is highly mitotically active. Systemic stressors during COVID-19 can cause a <strong>temporary cessation of matrix proliferation<\/strong>, resulting in:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Beau\u2019s lines<\/li>\n\n\n\n<li>Onychomadesis (severe cases)<\/li>\n<\/ul>\n\n\n\n<p>This mechanism is analogous to other febrile illnesses but more frequently reported due to the high global burden of SARS-CoV-2 infection.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">3.2 Microvascular injury<\/h2>\n\n\n\n<p>COVID-19 causes endothelial dysfunction characterized by:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Endothelial swelling<\/li>\n\n\n\n<li>Microthrombi formation<\/li>\n\n\n\n<li>Capillary rarefaction<\/li>\n\n\n\n<li>Perivascular inflammation<\/li>\n<\/ul>\n\n\n\n<p>These changes reduce perfusion to the nail matrix and nail bed, contributing to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Transverse leukonychia<\/li>\n\n\n\n<li>Nail plate dyschromia<\/li>\n\n\n\n<li>Growth slowing<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">3.3 Inflammatory injury<\/h2>\n\n\n\n<p>Elevated cytokines impair keratinocyte function via:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NF-\u03baB pathway activation<\/li>\n\n\n\n<li>Oxidative stress<\/li>\n\n\n\n<li>Disruption of keratin filament assembly<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">4. Histopathology of COVID-19\u2013Associated Nail Changes<\/h1>\n\n\n\n<p>Histopathologic data are limited but can be inferred from periungual biopsies and COVID-19 skin pathology studies.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">4.1 Nail matrix histopathology<\/h2>\n\n\n\n<p>Reported and inferred findings include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Focal matrix keratinocyte apoptosis<\/strong><\/li>\n\n\n\n<li><strong>Reduced mitotic activity in germinal matrix<\/strong><\/li>\n\n\n\n<li><strong>Spongiosis in nail matrix epithelium (rare)<\/strong><\/li>\n\n\n\n<li><strong>Parakeratosis of nail plate formation zones<\/strong><\/li>\n\n\n\n<li><strong>Disruption of normal keratin filament alignment<\/strong><\/li>\n<\/ul>\n\n\n\n<p>These findings correlate with transient interruption of nail production.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">4.2 Nail bed and periungual tissue<\/h2>\n\n\n\n<p>Common histopathologic features include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Endothelial swelling and vacuolization<\/strong><\/li>\n\n\n\n<li><strong>Perivascular lymphocytic infiltrates<\/strong><\/li>\n\n\n\n<li><strong>Microthrombi in superficial dermal vessels<\/strong><\/li>\n\n\n\n<li><strong>Deposition of complement components (C5b-9)<\/strong><\/li>\n\n\n\n<li><strong>Red cell extravasation in severe cases<\/strong><\/li>\n<\/ul>\n\n\n\n<p>These findings are consistent with COVID-19\u2013associated systemic microangiopathy.\u00b9<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">4.3 Vascular pathology<\/h2>\n\n\n\n<p>Electron microscopy and immunohistochemical studies in COVID-19 skin demonstrate:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Endothelial cell injury with viral-like particles (controversial)<\/li>\n\n\n\n<li>Increased von Willebrand factor expression<\/li>\n\n\n\n<li>Platelet aggregation within dermal capillaries<\/li>\n<\/ul>\n\n\n\n<p>These vascular changes plausibly extend to the nail unit, explaining ischemic nail matrix dysfunction.\u00b2<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">4.4 Comparison to other conditions<\/h2>\n\n\n\n<p>COVID-19 nail histology resembles:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Severe febrile illness\u2013associated Beau\u2019s lines<\/li>\n\n\n\n<li>Kawasaki disease\u2013associated nail bed inflammation<\/li>\n\n\n\n<li>Drug-induced nail matrix arrest<\/li>\n<\/ul>\n\n\n\n<p>However, COVID-19 shows more prominent <strong>microvascular thrombotic features<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">5. Clinical Nail Manifestations<\/h1>\n\n\n\n<h2 class=\"wp-block-heading\">5.1 Beau\u2019s lines<\/h2>\n\n\n\n<p>Transverse depressions caused by temporary cessation of nail growth.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Appear 2\u20138 weeks after infection<\/li>\n\n\n\n<li>Reflect timing of systemic insult<\/li>\n\n\n\n<li>Grow out with nail plate<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">5.2 Onychomadesis<\/h2>\n\n\n\n<p>Proximal nail shedding due to complete matrix arrest.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>More common in severe or hospitalized cases<\/li>\n\n\n\n<li>May affect multiple nails simultaneously<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">5.3 Transverse chromonychia (\u201cCOVID nails\u201d)<\/h2>\n\n\n\n<p>Red, white, or mixed transverse bands likely due to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vascular inflammation<\/li>\n\n\n\n<li>Temporary ischemia<\/li>\n\n\n\n<li>Keratinization disruption<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">5.4 Mees\u2019 lines (leukonychia striata)<\/h2>\n\n\n\n<p>White transverse bands reflecting systemic toxicity or metabolic stress.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">5.5 Nail growth retardation<\/h2>\n\n\n\n<p>Reduced nail growth rate persists for weeks to months after recovery.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">6. Clinical Presentation<\/h1>\n\n\n\n<h2 class=\"wp-block-heading\">6.1 Timing<\/h2>\n\n\n\n<p>Nail changes appear delayed due to slow growth:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fingernails: 2\u20138 weeks post-infection<\/li>\n\n\n\n<li>Toenails: 6\u201312 weeks post-infection<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">6.2 Symptoms<\/h2>\n\n\n\n<p>Most patients are asymptomatic, with:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cosmetic nail changes<\/li>\n\n\n\n<li>Rare tenderness in periungual region<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">6.3 Distribution<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Often multiple fingernails<\/li>\n\n\n\n<li>Toenails less commonly but more persistently affected<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">7. Complications<\/h1>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cosmetic distress<\/li>\n\n\n\n<li>Anxiety and misdiagnosis as fungal disease<\/li>\n\n\n\n<li>Rare secondary onychomycosis due to nail disruption<\/li>\n\n\n\n<li>Chronic brittle nail syndrome in prolonged systemic illness<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">8. Therapeutic Approaches<\/h1>\n\n\n\n<h2 class=\"wp-block-heading\">8.1 General principles<\/h2>\n\n\n\n<p>No antiviral or disease-specific nail therapy is required.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">8.2 Supportive management<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Nutritional optimization (protein, zinc, iron)<\/li>\n\n\n\n<li>Gentle nail care and protection<\/li>\n\n\n\n<li>Avoidance of trauma and harsh chemicals<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">8.3 Diagnostic caution<\/h2>\n\n\n\n<p>Important to exclude:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Onychomycosis (KOH\/culture)<\/li>\n\n\n\n<li>Psoriatic nail disease<\/li>\n\n\n\n<li>Drug-induced dystrophy<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">8.4 Dermatologic referral<\/h2>\n\n\n\n<p>Indicated for:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Severe onychomadesis<\/li>\n\n\n\n<li>Persistent nail deformity<\/li>\n\n\n\n<li>Diagnostic uncertainty<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">9. Outcomes<\/h1>\n\n\n\n<h2 class=\"wp-block-heading\">9.1 Natural history<\/h2>\n\n\n\n<p>Most nail abnormalities are:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Self-limited<\/li>\n\n\n\n<li>Fully reversible<\/li>\n<\/ul>\n\n\n\n<p>Resolution timeline:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fingernails: 3\u20136 months<\/li>\n\n\n\n<li>Toenails: 6\u201312 months<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">9.2 Prognostic significance<\/h2>\n\n\n\n<p>Nail findings correlate loosely with:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Severity of systemic inflammation<\/li>\n\n\n\n<li>Duration of fever<\/li>\n\n\n\n<li>Hospitalization or ICU admission<\/li>\n<\/ul>\n\n\n\n<p>They may serve as a <strong>retrospective marker of disease severity<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">9.3 Long-term outcomes<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Permanent nail damage: rare<\/li>\n\n\n\n<li>Recurrence: uncommon<\/li>\n\n\n\n<li>Persistent brittleness: occasionally reported in long COVID<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">10. Discussion<\/h1>\n\n\n\n<p>COVID-19 nail abnormalities represent a <strong>delayed epiphenomenon of systemic inflammatory and vascular injury rather than direct viral cytopathy<\/strong>. The nail matrix acts as a biologic recorder of systemic stress.<\/p>\n\n\n\n<p>Histopathologic findings support a dual mechanism:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Transient matrix arrest due to inflammatory cytokines<\/strong><\/li>\n\n\n\n<li><strong>Microvascular dysfunction with endothelial injury and microthrombi<\/strong><\/li>\n<\/ol>\n\n\n\n<p>This vascular-inflammatory paradigm aligns with broader COVID-19 pathophysiology affecting multiple organ systems.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">11. Conclusion<\/h1>\n\n\n\n<p>SARS-CoV-2\u2013associated nail changes are benign, delayed manifestations of systemic illness characterized by nail matrix growth arrest and microvascular dysfunction. Histopathology demonstrates keratinocyte suppression and endothelial injury rather than direct viral invasion. Recognition of these patterns aids clinical diagnosis and reinforces the systemic nature of COVID-19.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h1 class=\"wp-block-heading\">Footnotes \/ References<\/h1>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. <em>Translational Research<\/em>. 2020.<\/li>\n\n\n\n<li>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. <em>Lancet<\/em>. 2020;395:1417\u20131418.<\/li>\n\n\n\n<li>Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. <em>J Eur Acad Dermatol Venereol<\/em>. 2020.<\/li>\n\n\n\n<li>Galv\u00e1n Casas C, et al. Classification of COVID-19 cutaneous manifestations. <em>Br J Dermatol<\/em>. 2020.<\/li>\n\n\n\n<li>Wollina U. COVID-19 and skin: a systematic review. <em>Clin Dermatol<\/em>. 2021.<\/li>\n\n\n\n<li>Daniel CR 3rd, et al. Beau lines and systemic disease: nail growth arrest physiology. <em>Dermatol Clin<\/em>. 2015.<\/li>\n\n\n\n<li>Piraccini BM, et al. Nail disorders in systemic disease. <em>Lancet Dermatology Review<\/em>. 2018.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>John Murphy, CEO, The COVID-19 Long Haul Foundation Abstract SARS-CoV-2 infection has been associated with delayed nail abnormalities including Beau\u2019s lines, onychomadesis, transverse leukonychia, and chromonychia (\u201cCOVID nails\u201d). These manifestations [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":14566,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[661,106,1145,242,1322,1144],"tags":[],"class_list":["post-14564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ace2-receptors","category-cytokine-storm","category-finger-nail","category-il-6","category-tnf-","category-toe-nail"],"_links":{"self":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/14564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14564"}],"version-history":[{"count":1,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/14564\/revisions"}],"predecessor-version":[{"id":14565,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/14564\/revisions\/14565"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/media\/14566"}],"wp:attachment":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}